mHealth Market

mHealth Market (Product: Connected Medical Devices, mHealth Applications, and mHealth Services; and End-user: B2B and B2C) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

mHealth Market Outlook 2031

  • The global industry was valued at US$ 97.0 Bn in 2022
  • It is estimated to advance at a CAGR of 15.3% from 2023 to 2031 and reach US$ 353.4 Bn by the end of 2031

Analyst Viewpoint

Increase in popularity of remote patient monitoring devices and technological advancements in the healthcare sector are fueling the mHealth market size. mHealth enables monitoring real-time patient information to track their heart rate, sugar levels, blood pressure, and other parameters. Rise in demand for remote patient monitoring devices for chronic diseases is driving the demand for mobile healthcare services.

Surge in adoption of digital health and easy availability of wearable fitness trackers is boosting market expansion. Increase in government initiatives to promote fitness awareness is likely to offer lucrative mHealth market opportunities. Leading companies in the sector are launching new applications with advanced technologies to meet patient demands. Moreover, manufacturers are investing in research and development activities to analyze the requirements of physicians and develop relevant services accordingly.

Mhealth Market

Market Introduction

mHealth or mobile health is a general term for the use of mobile phones and other wireless technology in medical care. mHealth is used to improve health outcomes, research, and healthcare services to enhance patient care. These are available in devices, connections, applications, and service forms. mHealth plays a crucial part in telemedicine by increasing patient interaction and enabling remote data access to healthcare providers.

Digital health is on the rise across the globe due to the availability of advanced technologies and accessibility to modern healthcare services. mHealth enables mobile self-care services for patients suffering from diabetes, chronic diseases, and other health issues. The technology simplifies interaction among patients and allows physicians to access real-time patient data, such as sugar level, blood pressure, and heart rate.

Increase in Popularity of Remote Patient Monitoring Devices Fostering mHealth Market Growth

Remote patient monitoring devices are extensively utilized by healthcare professionals to track patient information and change the treatment mode as per the requirements. Mobile healthcare devices are employed to monitor patient data where patients can update their details at their end. These devices help provide better treatment, increase patient engagement, reduce patient visits to the hospitals, decrease healthcare costs, and keep patient data updated. Thus, increase in popularity of advanced remote patient monitoring devices is fueling mHealth market value.

Rise in demand for remote patient monitoring solutions for chronic conditions is bolstering the market statistics. Chronic conditions, such as diabetes, cancer, and heart disease require regular patient data monitoring to avoid severe issues and disabilities. mHealth allows patients to register their blood sugar levels, heart rate, and other symptoms through remote devices. Hence, increase in prevalence of chronic conditions is driving market revenue.

According to the American Hospital Association, around 133 million Americans, nearly half the population, suffer from at least one chronic condition, such as arthritis, hypertension, or heart disease. The number is estimated to reach approximately 170 million by 2030.

Technological Advancements in Healthcare Sector Augmenting Market Development

Increase in penetration of 5G connectivity, artificial intelligence, machine learning, and augmented reality are some of the trending technologies adopted by the healthcare sector. Incorporation of Internet of Things (IoT) in mHealth enhances connectivity and accessibility through remote networks. Leading companies in the market are investing heavily to develop advanced mobile health apps for diabetes management, which in turn is fueling market progress. For instance, AT&T collaborated with Smart Meter to develop advanced digital health solutions for monitoring and tracking chronic ailments, such as diabetes, using Smart Meter’s IoT devices and AT&T’s well-established IoT network.

Rise in demand for wearable fitness trackers for heart rate monitoring is boosting market dynamics. Manufacturers are employing motion detectors, temperature monitors, and sensors to precisely record patient data. People are keen on using wearable fitness trackers due to its high efficiency, accuracy, easy availability, and feasibility.

Regional Outlook

According to the regional mHealth market analysis, North America dominated the global landscape in 2022. Implementation of government initiatives to promote mHealth is likely to propel the mHealth industry share during the forecast period. For instance, the U.S. Department of Health and Human Services, the National Institutes of Health, and the National Cancer Institute initiated Smokefree.gov and BeTobaccoFree.gov, to spread awareness among the population. Leading companies in the region are adopting the latest technologies to introduce new applications and services for patients.

Increase in use of connected devices and mHealth applications to manage chronic conditions is fueling market growth. Availability of strong network connectivity and developed healthcare infrastructure is favoring market conditions in the region. Moreover, easy accessibility to advanced technologies allows companies to develop services according to patient requirements.

Analysis of Key Players in mHealth Industry

Leading companies in the market are focusing on adopting the latest technologies to meet recent mHealth market trends. They are incorporating IoT, artificial intelligence, motion sensors, and temperature trackers into wearable fitness trackers to monitor real-time patient data. Manufacturers are introducing new applications and services to increase patient engagement and enhance their fitness awareness.

Some of the key players in the industry are Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.

These companies have been profiled in the mHealth market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In October 2023, Cedars-Sinai, a leading company providing specialty care from expert physicians, introduced a new artificial intelligence-powered mobile health application, the Cedars-Sinai Connect. This application offers virtual care alternatives for various clinical issues with same-day primary care visits and round-the-clock virtual access to medical specialists for urgent treatment.
  • In March 2023, Apple Inc., a multinational technology company, announced plans to upgrade AirPods with health tracking features, including temperature monitors, motion detectors, and biometric sensors to detect perspiration and heart rate, by 2025.

mHealth Market Snapshot

Attribute Detail
Market Size in 2022 US$ 97.0 Bn
Market Forecast (Value) in 2031 US$ 353.4 Bn
Growth Rate (CAGR) 15.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Connected Medical Devices
      • Heart Rate Monitors
      • Activity Monitors
      • Electrocardiograph
      • Fetal Monitoring
      • Neuromonitoring
      • Others
    • mHealth Applications
      • Fitness & Wellness
      • Diabetes
      • Cardiovascular Diseases
      • Central Nervous System Diseases
      • Respiratory Diseases
      • Musculoskeletal Diseases
      • Smoking Cessation
      • Medication Adherence
      • Others
    • mHealth Services
  • End-user
    • B2B
      • Patients
      • Caregivers
    • B2C
      • Providers
      • Payers
      • Employers
      • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Dexcom, Inc.
  • Apple, Inc.
  • FitBit, Inc.
  • Withings
  • Proteus Digital Health, Inc.
  • Omada Health, Inc.
  • Welldoc, Inc.
  • Teladoc Health, Inc.
  • Noom, Inc.
  • Propeller Health
  • Canary Health
  • BiogeniQ Inc.
  • Glooko, Inc.
  • Firstbeat Technologies
  • BioTelemetry, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global mHealth market in 2022?

It was valued at US$ 97.0 Bn in 2022

How is the mHealth sector expected to grow by 2031?

It is projected to register a CAGR of 15.3% from 2023 to 2031

What are the key factors driving the demand for mHealth?

Increase in popularity of remote patient monitoring devices, and growth in technological advancements in the healthcare sector

Which was the most lucrative region in the mHealth industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent mHealth manufacturers?

Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.

    1. Executive Summary

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global mHealth Market

    4. Market Overview

        4.1. Market Segmentation

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global mHealth Market Analysis and Forecasts, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. COVID-19 Pandemic Impact on Industry

    6. mHealth Market Analysis and Forecast, by Product

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Connected Medical Devices

                6.3.1.1. Heart Rate Monitors

                6.3.1.2. Activity Monitors

                6.3.1.3. Electrocardiograph

                6.3.1.4. Fetal Monitoring

                6.3.1.5. Neuromonitoring

                6.3.1.6. Others

            6.3.2. mHealth Applications

                6.3.2.1. Fitness & Wellness

                6.3.2.2. Diabetes

                6.3.2.3. Cardiovascular Diseases

                6.3.2.4. Central Nervous System Diseases

                6.3.2.5. Respiratory Diseases

                6.3.2.6. Musculoskeletal Diseases

                6.3.2.7. Smoking Cessation

                6.3.2.8. Medication Adherence

                6.3.2.9. Others

            6.3.3. mHealth Services

        6.4. Market Attractiveness, by Product

    7. Global mHealth Market Analysis and Forecast, by End-user

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. B2B

                7.3.1.1. Patients

                7.3.1.2. Caregivers

            7.3.2. B2C

                7.3.2.1. Providers

                7.3.2.2. Payers

                7.3.2.3. Employers

                7.3.2.4. Others

        7.4. Market Attractiveness, by End-user

    8. Global mHealth Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2017–2031

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness, by Region

    9. North America mHealth Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product, 2017–2031

            9.2.1. Connected Medical Devices

                9.2.1.1. Heart Rate Monitors

                9.2.1.2. Activity Monitors

                9.2.1.3. Electrocardiograph

                9.2.1.4. Fetal Monitoring

                9.2.1.5. Neuromonitoring

                9.2.1.6. Others

            9.2.2. mHealth Applications

                9.2.2.1. Fitness & Wellness

                9.2.2.2. Diabetes

                9.2.2.3. Cardiovascular Diseases

                9.2.2.4. Central Nervous System Diseases

                9.2.2.5. Respiratory Diseases

                9.2.2.6. Musculoskeletal Diseases

                9.2.2.7. Smoking Cessation

                9.2.2.8. Medication Adherence

                9.2.2.9. Others

            9.2.3. mHealth Services

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. B2B

                9.3.1.1. Patients

                9.3.1.2. Caregivers

            9.3.2. B2C

                9.3.2.1. Providers

                9.3.2.2. Payers

                9.3.2.3. Employers

                9.3.2.4. Others

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe mHealth Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Connected Medical Devices

                10.2.1.1. Heart Rate Monitors

                10.2.1.2. Activity Monitors

                10.2.1.3. Electrocardiograph

                10.2.1.4. Fetal Monitoring

                10.2.1.5. Neuromonitoring

                10.2.1.6. Others

            10.2.2. mHealth Applications

                10.2.2.1. Fitness & Wellness

                10.2.2.2. Diabetes

                10.2.2.3. Cardiovascular Diseases

                10.2.2.4. Central Nervous System Diseases

                10.2.2.5. Respiratory Diseases

                10.2.2.6. Musculoskeletal Diseases

                10.2.2.7. Smoking Cessation

                10.2.2.8. Medication Adherence

                10.2.2.9. Others

            10.2.3. mHealth Services

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. B2B

                10.3.1.1. Patients

                10.3.1.2. Caregivers

            10.3.2. B2C

                10.3.2.1. Providers

                10.3.2.2. Payers

                10.3.2.3. Employers

                10.3.2.4. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific mHealth Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Connected Medical Devices

                11.2.1.1. Heart Rate Monitors

                11.2.1.2. Activity Monitors

                11.2.1.3. Electrocardiograph

                11.2.1.4. Fetal Monitoring

                11.2.1.5. Neuromonitoring

                11.2.1.6. Others

            11.2.2. mHealth Applications

                11.2.2.1. Fitness & Wellness

                11.2.2.2. Diabetes

                11.2.2.3. Cardiovascular Diseases

                11.2.2.4. Central Nervous System Diseases

                11.2.2.5. Respiratory Diseases

                11.2.2.6. Musculoskeletal Diseases

                11.2.2.7. Smoking Cessation

                11.2.2.8. Medication Adherence

                11.2.2.9. Others

            11.2.3. mHealth Services

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. B2B

                11.3.1.1. Patients

                11.3.1.2. Caregivers

            11.3.2. B2C

                11.3.2.1. Providers

                11.3.2.2. Payers

                11.3.2.3. Employers

                11.3.2.4. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America mHealth Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Connected Medical Devices

                12.2.1.1. Heart Rate Monitors

                12.2.1.2. Activity Monitors

                12.2.1.3. Electrocardiograph

                12.2.1.4. Fetal Monitoring

                12.2.1.5. Neuromonitoring

                12.2.1.6. Others

            12.2.2. mHealth Applications

                12.2.2.1. Fitness & Wellness

                12.2.2.2. Diabetes

                12.2.2.3. Cardiovascular Diseases

                12.2.2.4. Central Nervous System Diseases

                12.2.2.5. Respiratory Diseases

                12.2.2.6. Musculoskeletal Diseases

                12.2.2.7. Smoking Cessation

                12.2.2.8. Medication Adherence

                12.2.2.9. Others

            12.2.3. mHealth Services

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. B2B

                12.3.1.1. Patients

                12.3.1.2. Caregivers

            12.3.2. B2C

                12.3.2.1. Providers

                12.3.2.2. Payers

                12.3.2.3. Employers

                12.3.2.4. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa mHealth Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Connected Medical Devices

                13.2.1.1. Heart Rate Monitors

                13.2.1.2. Activity Monitors

                13.2.1.3. Electrocardiograph

                13.2.1.4. Fetal Monitoring

                13.2.1.5. Neuromonitoring

                13.2.1.6. Others

            13.2.2. mHealth Applications

                13.2.2.1. Fitness & Wellness

                13.2.2.2. Diabetes

                13.2.2.3. Cardiovascular Diseases

                13.2.2.4. Central Nervous System Diseases

                13.2.2.5. Respiratory Diseases

                13.2.2.6. Musculoskeletal Diseases

                13.2.2.7. Smoking Cessation

                13.2.2.8. Medication Adherence

                13.2.2.9. Others

            13.2.3. mHealth Services

        13.3. Market Value Forecast, by End-user, 2017–2031

            13.3.1. B2B

                13.3.1.1. Patients

                13.3.1.2. Caregivers

            13.3.2. B2C

                13.3.2.1. Providers

                13.3.2.2. Payers

                13.3.2.3. Employers

                13.3.2.4. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. Dexcom, Inc.

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Apple, Inc.

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. FitBit, Inc.

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Withings

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. Proteus Digital Health, Inc.

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. Financial Overview

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. Omada Health, Inc.

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Product Portfolio

                14.3.6.3. Financial Overview

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Welldoc, Inc.

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. Financial Overview

                14.3.7.4. SWOT Analysis

                14.3.7.5. Strategic Overview

            14.3.8. Teladoc Health, Inc.

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Product Portfolio

                14.3.8.3. Financial Overview

                14.3.8.4. SWOT Analysis

                14.3.8.5. Strategic Overview

            14.3.9. Noom, Inc.

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Product Portfolio

                14.3.9.3. Financial Overview

                14.3.9.4. SWOT Analysis

                14.3.9.5. Strategic Overview

            14.3.10. Propeller Health.

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Product Portfolio

                14.3.10.3. Financial Overview

                14.3.10.4. SWOT Analysis

                14.3.10.5. Strategic Overview

            14.3.11. Canary Health

                14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.11.2. Product Portfolio

                14.3.11.3. Financial Overview

                14.3.11.4. SWOT Analysis

                14.3.11.5. Strategic Overview

            14.3.12. BiogeniQ Inc.

                14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.12.2. Product Portfolio

                14.3.12.3. Financial Overview

                14.3.12.4. SWOT Analysis

                14.3.12.5. Strategic Overview

            14.3.13. Glooko, Inc.

                14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.13.2. Product Portfolio

                14.3.13.3. Financial Overview

                14.3.13.4. SWOT Analysis

                14.3.13.5. Strategic Overview

            14.3.14. Firstbeat Technologies

                14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.14.2. Product Portfolio

                14.3.14.3. Financial Overview

                14.3.14.4. SWOT Analysis

                14.3.14.5. Strategic Overview

            14.3.15. BioTelemetry, Inc.

                14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.15.2. Product Portfolio

                14.3.15.3. Financial Overview

                14.3.15.4. SWOT Analysis

                14.3.15.5. Strategic Overview

    List of Tables

    Table 01: Global mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 03: Global mHealth Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 04: North America mHealth Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 05: North America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 06: North America mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 07: Europe mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 08: Europe mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 09: Europe mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

    Table 10: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 11: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 12: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Latin America mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Latin America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 15: Latin America mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

    Table 16: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 18: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

    List of Figures

    Figure 01: Global mHealth Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global mHealth Market Value Share, by Product, 2022

    Figure 03: Global mHealth Market Value Share, by End-user, 2022

    Figure 04: Global mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 05: Global mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 06: Global mHealth Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 07: Global mHealth Market Attractiveness Analysis, by End-user 2023–2031

    Figure 08: Global mHealth Market Value Share Analysis, by Region, 2022 and 2031

    Figure 09: Global mHealth Market Attractiveness Analysis, by Region, 2023–2031

    Figure 10: North America mHealth Market Value (US$ Mn) Forecast, 2017–2031

    Figure 11: North America mHealth Market Value Share Analysis, by Country, 2022 and 2031

    Figure 12: North America mHealth Market Attractiveness Analysis, by Country, 2023–2031

    Figure 13: North America mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 14: North America mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 15: North America mHealth Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 16: North America mHealth Market Attractiveness Analysis, by End-user 2023–2031

    Figure 17: Europe mHealth Market Value (US$ Mn) Forecast, 2017–2031

    Figure 18: Europe mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 19: Europe mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 20: Europe mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 21: Europe America mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 22: Europe mHealth Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 23: Europe mHealth Market Attractiveness Analysis, by End-user 2023–2031

    Figure 24: Asia Pacific mHealth Market Value (US$ Mn) Forecast, 2017–2031

    Figure 25: Asia Pacific mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 26: Asia Pacific mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 27: Asia Pacific mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 28: Asia Pacific America mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 29: Asia Pacific mHealth Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 30: Asia Pacific mHealth Market Attractiveness Analysis, by End-user 2023–2031

    Figure 31: Latin America mHealth Market Value (US$ Mn) Forecast, 2017–2031

    Figure 32: Latin America mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 33: Latin America mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 34: Latin America mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 35: Latin America mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 36: Middle East & Africa mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 37: Middle East & Africa mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Middle East & Africa America mHealth Market Value Share Analysis, by Product, 2022 and 2031

    Figure 39: Middle East & Africa America mHealth Market Attractiveness Analysis, by Product, 2023–2031

    Figure 40: Middle East & Africa mHealth Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 41: Middle East & Africa mHealth Market Attractiveness Analysis, by End-user 2023–2031

    Figure 42: Global mHealth Market Share Analysis, by Company (2022)

Copyright © Transparency Market Research, Inc. All Rights reserved